---
created: 2025-04-13
updated: 2025-04-13T10:52
id: B<qJ+39UBH
specialty: pharmaco
specialty_id: 238
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::11-hematology::01-hemostasis::07-anticoagulants
  - "source/ak-step1-v11:": 
  - theme/firstaid::10-hematology-oncology::05-pharm::02-unfractionated-heparin
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::13-hematology-oncology::11-hemostasis
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::10-heme::heparin
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::01-anticoagulants-&-thrombolytics::01-heparin,-lmwh,-fondaparinux,-direct-thrombin-inhibitors,-xa-inhibitors
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield"
type: flashcard
---

# Question
What effect may heparin have on K+ levels?   **Increased (hyperkalemia; secondary to hypoaldosteronism)**

---

# Answer
Heparin inhibits an enzymatic step in synthesis of aldosterone and reduces the amount / activity of ATII receptors in the Zona Glomerulosa (prolonged usage damages the Zona Glomerulosa)